February 20 2018 - AstraZeneca licenses another Ionis antisense drug for $330 million

February 20 2018 - AstraZeneca licenses another Ionis antisense drug for $330 million

AstraZeneca licenses another Ionis antisense drug for $330 million, MiMedx shares tumble on investigation, ICER analysis of CAR-T drug costs, and more

Embed from Getty Images
Today's most popular searches:

For banking news and anonymous forums, be sure to check out cafebanking.com